Skip to main content
Back

ISO 10993-17:2023/Amd 1:2025

Biological evaluation of medical devices — Part 17: Toxicological risk assessment of medical device constituents — Amendment 1

General information

Valid from 18.11.2025
Directives or regulations
None

Standard history

Status
Date
Type
Name
18.11.2025
Amendment
13.09.2023
Main
Amendment to ISO 10993-17:2023

Required fields are indicated with *

*
*
*
PDF
24.01 € incl tax
Paper
24.01 € incl tax
Standard monitoring

Customers who bought this item also bought

Amendment

EVS-EN ISO 15223-1:2021/A1:2025

Medical devices - Symbols to be used with information to be supplied by the manufacturer - Part 1: General requirements - Amendment 1: Addition of defined term for authorized representative and modified EC REP symbol to not be country or region specific (ISO 15223 1:2021/Amd 1:2025)
Valid from 01.12.2025
Main + amendment

EVS-EN ISO 10993-12:2021+A1:2025

Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021 + ISO 10993 12:2021/Amd 1:2025)
Newest version Valid from 01.10.2025
Main + amendment

EVS-EN ISO 10993-23:2021+A1:2025

Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021 + ISO 10993- 23:2021/Amd 1:2025)
Newest version Valid from 01.09.2025
Amendment

EVS-EN ISO 11137-1:2015/A2:2019

Sterilization of health care products - Radiation - Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices - Amendment 2: Revision to 4.3.4 and 11.2 (ISO 11137-1:2006/Amd 2:2018)
Newest version Valid from 02.12.2019